Cantargia competitorsClear all

Cantargia's top competitors include MetaStat, NeOnc Technologies, Sonnet BioTherapeutics and CARsgen Therapeutics.
Cantargia
Cantargia
Cantargia is a biotechnology company that specializes in the development of pharmaceuticals for various types of cancer, autoimmune and inflammatory diseases.
MetaStat
MetaStat
MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.
NeOnc Technologies
NeOnc Technologies
NeOnc Technologies is an early-stage cancer biotechnology company focused on intranasal inhalation of monoterpene.
Sonnet BioTherapeutics
Sonnet BioTherapeutics
Sonnet BioTherapeutics is an oncology-focused biotechnology company.
CARsgen Therapeutics
CARsgen Therapeutics
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
Founding Date
Founding Date
2010
Founding Date
2010
Founding Date
2008
Founding Date
2011
Founding Date
2014
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Lund, SE HQ
Locations
Boston, US HQ
Locations
West Hollywood, US HQ
Locations
Princeton, US HQ
Locations
Shanghai, CN HQ
Beijing, CN
Shanghai, CN
Shanghai, CN
Bellaire, US
Employees
Employees
843% decrease
Employees
6
Employees
N/A
Employees
30
Employees
403% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
26 k
Valuation ($)
N/A
Valuation ($)
47.4 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
341
Twitter followers
4
Twitter followers
N/A
Twitter followers
39
Alexa Website Rank
Alexa Website Rank
281446
Alexa Website Rank
N/A
Alexa Website Rank
355077
Alexa Website Rank
265217
Alexa Website Rank
55264

Financial

Net income
Net income
N/A
Net income
($3.2m) (FY, 2018)
Net income
N/A
Net income
($24.3m) (FY, 2020)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 150k (over 8 years ago)
Latest funding round
N/A
Latest funding round
$ 186m (3 months ago)
Total funding raised
Total funding raised
$ 1m
Total funding raised
$ 350k
Total funding raised
N/A
Total funding raised
$ 750k
Total funding raised
$ 276m
For sources of this data, please see the company profile

View company profiles

MetaStat
HQ
Boston, US
Employees
6

MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.

View company
NeOnc Technologies
HQ
West Hollywood, US

NeOnc Technologies is an early-stage cancer biotechnology company focused on intranasal inhalation of monoterpene.

View company
Sonnet BioTherapeutics
HQ
Princeton, US
Employees
30

Sonnet BioTherapeutics is an oncology-focused biotechnology company.

View company
CARsgen Therapeutics
HQ
Shanghai, CN
Employees
40↑ 3% increase

CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.

View company